PMID- 35855646 OWN - NLM STAT- MEDLINE DCOM- 20221229 LR - 20230413 IS - 1879-0844 (Electronic) IS - 1388-9842 (Print) IS - 1388-9842 (Linking) VI - 24 IP - 12 DP - 2022 Dec TI - Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM-HFpEF). PG - 2275-2284 LID - 10.1002/ejhf.2619 [doi] AB - AIMS: This pilot study aimed to assess the potential benefits of cardiac contractility modulation (CCM) in patients with heart failure with preserved ejection fraction (HFpEF). METHODS AND RESULTS: This was a prospective, multicentre, single-arm, pilot study of CCM therapy in patients with HFpEF and New York Heart Association (NYHA) class II or III. Echocardiographic parameters were measured by an echo core laboratory to determine study eligibility. After CCM device implantation, patients were followed for 24 weeks. Overall, 47 patients (mean age 74.3 +/- 4.4 years, 70.2% female) were enrolled, with left ventricular ejection fraction of 59 +/- 4.4%, 63.8% with hypertension, 46.8% with atrial fibrillation, 40.4% with diabetes, 31.9% with at least one heart failure hospitalization in the prior year, 61.7% in NYHA class III, and Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score of 48.9 +/- 21.7. The primary efficacy endpoint (mean change in the KCCQ overall summary score) improved by 18.0 +/- 16.6 points (p < 0.001) and there was an event-free rate of 93.6% for the primary safety endpoint (device- and procedure-related complications), as adjudicated by an independent physician committee. CONCLUSION: This pilot study demonstrates that the benefits of CCM may extend to the HFpEF patient population. The significant improvement in health status observed, with no obvious impact on safety, suggests that utilization of CCM for patients with HFpEF could prove to be promising. CI - (c) 2022 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. FAU - Linde, Cecilia AU - Linde C AD - Heart, Vascular and Neurology Theme, Karolinska University Hospital and the Karolinska Institutet, Stockholm, Sweden. FAU - Grabowski, Marcin AU - Grabowski M AD - Department of Cardiology, Medical University of Warsaw, Department of Cardiology, Warsaw, Poland. FAU - Ponikowski, Piotr AU - Ponikowski P AD - Impulse Dynamics (USA), Inc, Marlton, NJ, USA. FAU - Rao, Ishu AU - Rao I AD - Department of Heart Diseases, Medical University, Wroclaw University Centre for Heart Diseases, University Hospital, Wroclaw, Poland. FAU - Stagg, Angela AU - Stagg A AD - Clinical and Data Operations, Impulse Dynamics (USA), Inc, Marlton, NJ, USA. FAU - Tschope, Carsten AU - Tschope C AD - Berlin Institute of Health Center for Regenerative Therapies, and Department of Cardiology, Charite University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220811 PL - England TA - Eur J Heart Fail JT - European journal of heart failure JID - 100887595 SB - IM CIN - Eur J Heart Fail. 2022 Dec;24(12):2285-2286. PMID: 36036708 MH - Humans MH - Female MH - Aged MH - Male MH - *Heart Failure/therapy MH - Stroke Volume MH - Pilot Projects MH - Prospective Studies MH - Ventricular Function, Left MH - Health Status PMC - PMC10087783 OTO - NOTNLM OT - Cardiac contractility modulation OT - Device therapy OT - Health status OT - Heart failure OT - Heart failure with preserved ejection fraction OT - Kansas City Cardiomyopathy Questionnaire EDAT- 2022/07/21 06:00 MHDA- 2022/12/30 06:00 PMCR- 2023/04/11 CRDT- 2022/07/20 03:33 PHST- 2022/07/06 00:00 [revised] PHST- 2022/04/26 00:00 [received] PHST- 2022/07/08 00:00 [accepted] PHST- 2022/07/21 06:00 [pubmed] PHST- 2022/12/30 06:00 [medline] PHST- 2022/07/20 03:33 [entrez] PHST- 2023/04/11 00:00 [pmc-release] AID - EJHF2619 [pii] AID - 10.1002/ejhf.2619 [doi] PST - ppublish SO - Eur J Heart Fail. 2022 Dec;24(12):2275-2284. doi: 10.1002/ejhf.2619. Epub 2022 Aug 11.